Navigation Links
Peregrine Reports Data Showing Bavituximab's Potential to Shrink Prostate Tumors
Date:9/7/2007

- Adding Bavituximab to Standard Regimen of Androgen Deprivation and Chemotherapy Reduced Size of Formerly Resistant Tumors by More than Half -

- Data Further Confirm Bavituximab's Potential to Enhance Multiple

Combination Regimens for Cancer Therapy -

ATLANTA, and TUSTIN, Calif., Sept. 7 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing targeted monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection, today reported new preclinical studies showing an equivalent of its lead antibody bavituximab significantly shrank resistant human prostate tumors in mice when added to a standard regimen of androgen deprivation and docetaxel. The study findings will be presented today at the Innovative Minds in Prostate Cancer Today (IMPaCT) Conference in Atlanta by Dr. Yi Yin, a post-doctoral fellow in the laboratory of Dr. Philip Thorpe at UT Southwestern Medical Center in Dallas.

"These exciting results mimic the real life situation facing many prostate cancer patients whose disease is failing to respond to the standard combination of androgen deprivation and chemotherapy drugs such as docetaxel," said Dr. Thorpe. "In this study of human prostate tumors in mice, we have shown that administering a bavituximab equivalent significantly enhances the tumors' response to androgen deprivation and docetaxel, with the result that these large resistant tumors shrank by an average of more than 50% over the 13-week study. These findings further strengthen the rationale for use of bavituximab as part of combination therapy regimens for the treatment of prostate cancer."

Prostate cancer is the
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
2. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
3. Peregrine Pharmaceuticals Highlights Significant Advances in the Companys Clinical and Preclinical Cancer Programs Presented This Week at the AACR Annual Meeting
4. Data Presented at AACR Meeting Shows Peregrines Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
5. Data Presented at AACR Meeting Show Peregrines Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer
6. Data Presented at AACR Meeting Shows Peregrines Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
11. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)..., Dec. 1 TargeGen has announced th...rom a multi-center, US-based clinical,trial of TG...been scheduled at,the 2008 American Society of He...presentation are as follows:, Title: ...ailable, JAK2-Selective In...
(Date:12/1/2008)...study shows the Prox1 gene is a two-way switch tha...ls to be reprogrammed so that they lose their iden..., , MEMPHIS, Tenn., Dec. 1 /PRNewswire-USNe...arch Hospital have discovered that a certain diffe...tity that it requires the constant expression of a...
(Date:12/1/2008)...ence Call Scheduled for Tuesday, December 9 at 11:...- , , SOUTH SAN FRANCISCO, Calif., Dec. 1 ...s, Inc. (Nasdaq: SNSS ), a biopharmaceutical com...ion of new oncology therapeutics, today announced ...eloid leukemia (AML) will be presented during the ...
(Date:11/30/2008)...Dec. 1 Abnormalities in... in children with autism spectrum disorder by usin...dy presented today at the annual meeting of the Ra..., "Using MEG, we can record the tiny magnetic f...said Timothy Roberts, Ph.D., vice chair of researc...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Northwest Secures US 241 0 Million Debt Financing 8035 1Northwest Secures US 241 0 Million Debt Financing 8035 2Northwest Secures US 241 0 Million Debt Financing 8035 3Northwest Secures US 241 0 Million Debt Financing 8035 4TorreyPines Therapeutics Reports Successful End of Phase II Meeting With FDA for Tezampanel 8033 1TorreyPines Therapeutics Reports Successful End of Phase II Meeting With FDA for Tezampanel 8033 2TorreyPines Therapeutics Reports Successful End of Phase II Meeting With FDA for Tezampanel 8033 3TorreyPines Therapeutics Reports Successful End of Phase II Meeting With FDA for Tezampanel 8033 4Invest in Kids Rally to Be Held Before St Louis Vice Presidential Debate 26966 1Invest in Kids Rally to Be Held Before St Louis Vice Presidential Debate 26966 2Maryland Stem Cell Commission Issues Requests for Applications 26961 1Maryland Stem Cell Commission Issues Requests for Applications 26961 2Maryland Stem Cell Commission Issues Requests for Applications 26961 3
(Date:12/1/2008)...TER, Minn. - Disturbing evidence of higher mortali...h mitral valve prolapse and severe leakage may be ...ion,s severity in women, according to findings of ...nnals of Internal Medicine . , Mitral valve prol...dwide and often requires cardiac surgery, preferab...
(Date:12/1/2008)...Walker Chooses Two Tampa Beneficiaries for Par and...TAMPA, Fla., Dec. 1 The...arity of Tampa Bay, Inc. and the Judeo Christian H...the 2009 Par and Poker Celebrity Challenge for Cha..., , "It is only appropriate that events lik...
(Date:12/1/2008)..., nicotine use, personality illnesses common, stud...ews) -- Psychiatric disorders are common among you...ment, a new report shows. , To reach this findi...5,000 respondents, aged 19 to 25, who took part in...Related Conditions. , The study found that 45.8...
(Date:12/1/2008)...TON, Dec. 1 Democratic ...ed the following statement commemorating World AID...http://www.newscom.com/cgi-bin/prnh/20080519/DNCLO...t World AIDS Day, and while we have made strides, ...ic with both a national and global strategy. We m...
Breaking Medicine News(10 mins):Health News:Women with mitral valve prolapse are treated less aggressively than men and may be at high risk 2Health News:Celebrity Event Gives Local Non-Profits a Reason to be Thankful 2Health News:Few Young Adults Seek Treatment for Psych Disorders 2
...n by surgeons who no longer stand by the patient, ... The International Journal of Medical Robotics and...urgeons and scientists have shown that the surgeon...le Internet connection. Robots are starting to pro...
...onmental Protection announced today that aerial sp...mosquito larvae in Philadelphia have been resched...oLex CG, which is not a chemical pesticide, but is...that targets mosquito and black fly larvae when ad...
...known as integrin alpha 7 (integrin 7) lead to unc...cer, report researchers at the University of Pitt...ed today in the Journal of the National Cancer Ins...a7 represents an important new target for cancer t...
...5N1 strain of bird flu has been detected among pou...n capital, officials said Wednesday. The virus w... Sungai Buloh area of Selangor state, said Kamarud...se control section at the Department of Veterinary...
Other Medicine News:Health News:Robotic Surgery A Cutting Edge in Medical Field 2Health News:Rescheduled: Aerial Mosquito Treatment for Philadelphia 2Health News:A New Target for Cancer Therapy-Integrin Alpha7 Molecule 2Health News:A New Target for Cancer Therapy-Integrin Alpha7 Molecule 3Health News:A New Target for Cancer Therapy-Integrin Alpha7 Molecule 4Health News:Bird Flu Reappears in Malaysia 2
The generously sized STERILE VIEW Monk Hood from DePuy provides splash protection in the chin and neck areas from body fluids and liquids. Shoulder cut outs and ties ensure a comfortable fit. This pr
...he Nidek NM-200D's compact, lightweight body with ...more options to treat more patients, more comforta... operation and functionality for image capture, pr...ge data to the compact flash card. Through USB int...
PacePath is a comprehensive anatomic pathology software system that is the culmination of more than five years of development and testing by leading industry experts.
...abNet LIS is a Windows NT client server system tha...ity, power and high-speed volume required to meet ...ndustry experts, LabNet is structured to make gene...fective as possible. Our system can upload lab act...
Medicine Products: